Compounds > dacarbazine

dacarbazine and Icterus

dacarbazine has been researched along with Icterus in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carilli, A; Pellini Ferreira, B; Vasquez, J1
Adeyi, O; Fung, S; Mason, M; Millar, BA1
Bardier, A; Blot, E; Decaudin, D; Pouillart, P; Veyradier, A; Zagame, OL1
Apak, H; Celkan, T; Ozbay, G; Ozkan, A; Yildiz, I; Yoruk, A1

Reviews

1 review(s) available for dacarbazine and Icterus

ArticleYear
The vanishing bile duct syndrome in a child with Hodgkin disease.
    Medical and pediatric oncology, 2001, Volume: 36, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bile Duct Diseases; Bleomycin; Child, Preschool; Dacarbazine; Doxorubicin; Fatal Outcome; Hodgkin Disease; Humans; Jaundice; Male; Syndrome; Vinblastine

2001

Other Studies

3 other study(ies) available for dacarbazine and Icterus

ArticleYear
Metastatic Hepatoid Carcinoma of the Pancreas: First Description of Treatment With Capecitabine and Temozolomide.
    The American journal of the medical sciences, 2017, Volume: 353, Issue:6

    Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Biopsy; Capecitabine; Carcinoma, Hepatocellular; Dacarbazine; Glucagon; Glucagonoma; Humans; Jaundice; Liver; Male; Neoplasm Metastasis; Pancreatic Neoplasms; Prognosis; Temozolomide; Treatment Outcome

2017
Vanishing bile duct syndrome in the context of concurrent temozolomide for glioblastoma.
    BMJ case reports, 2014, Nov-28, Volume: 2014

    Topics: Antineoplastic Agents, Alkylating; Biopsy, Needle; Brain Neoplasms; Chemical and Drug Induced Liver Injury; Cholestyramine Resin; Common Bile Duct Diseases; Dacarbazine; Female; Follow-Up Studies; Glioblastoma; Humans; Immunohistochemistry; Jaundice; Liver Function Tests; Middle Aged; Syndrome; Temozolomide; Treatment Outcome; Ursodeoxycholic Acid

2014
Cancer-related thrombotic microangiopathy secondary to Von Willebrand factor-cleaving protease deficiency.
    Thrombosis research, 2002, Apr-15, Volume: 106, Issue:2

    Topics: ADAM Proteins; ADAMTS13 Protein; Adenocarcinoma; Anemia, Hemolytic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; CA-19-9 Antigen; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Esophageal Neoplasms; Fatal Outcome; Female; Humans; Ifosfamide; Jaundice; Metalloendopeptidases; Middle Aged; Neoplasms, Multiple Primary; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Paraneoplastic Syndromes; Sarcoma; Thrombocytopenia; von Willebrand Factor

2002